Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Switglim MV 1mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Switglim MV 1mg/500mg/0.3mg Tablet

Glucovance Plus 1mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combined-therapy formulation manages type 2 diabetes in adults by regulating blood glucose. Administer Glucovance Plus with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without consulting your doctor can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, manifesting as sweating, dizziness, headache, and tremors. Learn to recognize and treat hypoglycemia; regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Switglim MV 1mg/500mg/0.3mg Tablet

Managing Type 2 Diabetes

Major Benefits of Switglim MV 1mg/500mg/0.3mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Switglim MV 1mg/500mg/0.3mg Tablets should be administered on an empty stomach.

Common Side effects of Switglim MV 1mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Switglim MV 1mg/500mg/0.3mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Switglim MV 1mg/500mg/0.3mg tablet on an empty stomach.

How Switglim MV 1mg/500mg/0.3mg Tablet works:

One tablet of Switglim MV contains 1 mg, 500 mg, and 0.3 mg of three different antidiabetic medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Switglim MV 1mg/500mg/0.3mg Tablet with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Switglim MV 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Switglim MV 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Employing Switglim MV 1mg/500mg/0.3mg tablets in individuals with kidney disease carries a significant risk and is best avoided. Medical advice is essential. Furthermore, this medication is unsuitable for patients exhibiting severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Switglim MV 1mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; the medication is unsuitable for patients with severe hepatic dysfunction.

What if you forget to take Switglim MV 1mg/500mg/0.3mg Tablet :

Should you forget a dose of Switglim MV 1mg/500mg/0.3mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Switglim MV 1mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Switglim MV 1mg/500mg/0.3mg Tablet

Switglim MV 1mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not for type 1 diabetes.
Switglim MV 1mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infection.
Switglim MV 1mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any ingredient or excipient. Their use is also contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Switglim MV 1mg/500mg/0.3mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Switglim MV 1mg/500mg/0.3mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Switglim MV 1mg/500mg/0.3...
127
MRP 147
13% off